Introduction: Percutaneous transluminal angioplasty (PTA) is an established alternative to surgical 
bypass for the treatment of infrainguinal peripheral arterial disease in patients of limited life 
expectancy, poor surgical candidates, or those who lack adequate venous conduit. Aim of the work
This study was undertaken in an effort to evaluate the efficacy of angioplasty as a primary choice for 
the management of infrapopliteal arterial diseases.Infrapopliteal angioplasty (percutaneous ransluminal 
angioplasty (PTA)) is routinely used to treat critical limb ischemia (CLI) despite limited data on long-term outcomes. Results: This prospective study was conducted in El-Minia University Hospital after 
being approved by the faculty ethical committee. This study included 30 patients who presented to 
outpatient clinics or admitted in hospitals with critical lower limb ischemia with infrapopliteal arterial 
diseases. Summary: This study was conducted from July 2018 through February 2019. It included 
thirty patients who have been admitted to the vascular surgery department at Minia University Hospitals. 
Patients have been admitted one or two days before intervention to be prepared for endovascular 
intervention.